142 related articles for article (PubMed ID: 37506822)
41. Tp-e interval and Tp-e/QT ratio and their association with left ventricular diastolic dysfunction in Fabry disease without left ventricular hypertrophy.
Yenerçağ M; Arslan U
J Electrocardiol; 2020; 59():20-24. PubMed ID: 31945689
[TBL] [Abstract][Full Text] [Related]
42. Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab.
Thompson EW; Demissei BG; Smith AM; Brahmbhatt P; Wang J; Clark A; DeMichele A; Narayan V; Shah P; Sun L; Lefebvre B; Fradley MG; Carver JR; Tang WHW; Ky B
JACC Basic Transl Sci; 2022 Jan; 7(1):1-10. PubMed ID: 35128203
[TBL] [Abstract][Full Text] [Related]
43. The role of exercise in the prevention of cancer therapy-related cardiac dysfunction in breast cancer patients undergoing chemotherapy: systematic review.
Murray J; Bennett H; Bezak E; Perry R
Eur J Prev Cardiol; 2022 Mar; 29(3):463-472. PubMed ID: 33693524
[TBL] [Abstract][Full Text] [Related]
44. Assessment of Ventricular Repolarization in Sickle Cell Anemia Patients: The Role of QTc Interval, Tp-e Interval and Tp-e/QTc Ratio and Its Gender Implication.
Ajibare AO; Olabode OP; Fagbemiro EY; Akinlade OM; Akintunde AA; Akinpelu OO; Olatunji LA; Soladoye AO; Opadijo OG
Vasc Health Risk Manag; 2020; 16():525-533. PubMed ID: 33324066
[TBL] [Abstract][Full Text] [Related]
45. Long-term QT prolongation in monkeys after doxorubicin administration at doses similar to breast cancer therapy.
Bodziock GM; Meléndez GC
Front Cardiovasc Med; 2023; 10():1247273. PubMed ID: 38152607
[TBL] [Abstract][Full Text] [Related]
46. Can global longitudinal strain (GLS) with magnetic resonance prognosticate early cancer therapy-related cardiac dysfunction (CTRCD) in breast cancer patients, a prospective study?
Kar J; Cohen MV; McQuiston SA; Malozzi CM
Magn Reson Imaging; 2023 Apr; 97():68-81. PubMed ID: 36581216
[TBL] [Abstract][Full Text] [Related]
47. Screening for
Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
[TBL] [Abstract][Full Text] [Related]
48. Histopathological and epigenetic changes in myocardium associated with cancer therapy-related cardiac dysfunction.
Terada CI; Onoue K; Fujii T; Itami H; Morita K; Uchiyama T; Takeda M; Nakagawa H; Nakano T; Baba Y; Amemiya K; Saito Y; Hatakeyama K; Ohbayashi C
ESC Heart Fail; 2022 Oct; 9(5):3031-3043. PubMed ID: 35747987
[TBL] [Abstract][Full Text] [Related]
49. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.
Cardinale D; Colombo A; Bacchiani G; Tedeschi I; Meroni CA; Veglia F; Civelli M; Lamantia G; Colombo N; Curigliano G; Fiorentini C; Cipolla CM
Circulation; 2015 Jun; 131(22):1981-8. PubMed ID: 25948538
[TBL] [Abstract][Full Text] [Related]
50. Role of Myocardial Strain Imaging in Cancer Therapy-Related Cardiac Dysfunction.
Chaganti BT; Negishi K; Okajima K
Curr Cardiol Rep; 2022 Jun; 24(6):739-748. PubMed ID: 35522421
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of Tp-e interval, Tp-e/QT ratio and index of cardiac-electrophysiological balance in patients with tinnitus.
Kaya H; Suner A; Koparal M; Yucetas SC; Kafadar S
BMC Cardiovasc Disord; 2021 Aug; 21(1):415. PubMed ID: 34461839
[TBL] [Abstract][Full Text] [Related]
52. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients.
Nousiainen T; Jantunen E; Vanninen E; Hartikainen J
Br J Cancer; 2002 Jun; 86(11):1697-700. PubMed ID: 12087452
[TBL] [Abstract][Full Text] [Related]
53. Intravenous amiodarone homogeneously prolongs ventricular repolarization in patients with life-threatening ventricular tachyarrhythmia.
Kotake Y; Kurita T; Akaiwa Y; Yasuoka R; Motoki K; Kobuke K; Iwanaga Y; Miyazaki S
J Cardiol; 2015 Aug; 66(2):161-7. PubMed ID: 25468767
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19.
Yenerçağ M; Arslan U; Doğduş M; Günal Ö; Öztürk ÇE; Aksan G; Erdoğan G; Gül S; Yontar OC; Şen A
J Electrocardiol; 2020; 62():5-9. PubMed ID: 32731139
[TBL] [Abstract][Full Text] [Related]
55. The influence of type 2 diabetes and gender on ventricular repolarization dispersion in patients with sub-clinic left ventricular diastolic dysfunction.
Jani Y; Kamberi A; Xhunga S; Pocesta B; Ferati F; Lala D; Zeqiri A; Rexhepi A
Am J Cardiovasc Dis; 2015; 5(4):155-66. PubMed ID: 26550530
[TBL] [Abstract][Full Text] [Related]
56. Baseline Immunoglobulin E Levels as a Marker of Doxorubicin- and Trastuzumab-Associated Cardiac Dysfunction.
Beer LA; Kossenkov AV; Liu Q; Luning Prak E; Domchek S; Speicher DW; Ky B
Circ Res; 2016 Oct; 119(10):1135-1144. PubMed ID: 27582370
[TBL] [Abstract][Full Text] [Related]
57. An artificial intelligence approach for predicting cardiotoxicity in breast cancer patients receiving anthracycline.
Chang WT; Liu CF; Feng YH; Liao CT; Wang JJ; Chen ZC; Lee HC; Shih JY
Arch Toxicol; 2022 Oct; 96(10):2731-2737. PubMed ID: 35876889
[TBL] [Abstract][Full Text] [Related]
58. Prolonged repolarization in the early phase of ischemia is associated with ventricular fibrillation development in a porcine model.
Bernikova OG; Tsvetkova AS; Gonotkov MA; Ovechkin AO; Demidova MM; Azarov JE; Platonov PG
Front Physiol; 2023; 14():1035032. PubMed ID: 36755793
[No Abstract] [Full Text] [Related]
59. Variability of Myocardial Repolarization in Pediatric Patients with a Ventricular Septal Defect.
Uchida H; Nishio M; Omeki Y; Takeuchi Y; Nagata R; Oikawa S; Nagatani A; Eryu Y; Hata T; Yoshikawa T
Pediatr Cardiol; 2016 Dec; 37(8):1458-1464. PubMed ID: 27554253
[TBL] [Abstract][Full Text] [Related]
60. Spironolactone Attenuates Doxorubicin-induced Cardiotoxicity in Rats.
Liu G; Liu Y; Wang R; Hou T; Chen C; Zheng S; Dong Z
Cardiovasc Ther; 2016 Aug; 34(4):216-24. PubMed ID: 27097055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]